Woebot chatbot for substance use
An 8-week fully automated Woebot SUD program showed pre–post drops in substance use, cravings, depression, and anxiety in a single-group study.
Source
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study
What they did
101 adults who started Woebot for substance use (W-SUDs) completed an 8-week single-group pre–post evaluation of use occasions, AUDIT-C/DAST-10, cravings, confidence, PHQ-8, GAD-7, and pain.
What they found
Past-month use occasions, AUDIT-C, DAST-10, PHQ-8, and GAD-7 improved (all P<.05). In-app craving ratings fell roughly by half by weeks 8–9. Engagement averaged about 15.7 use days over 8 weeks. Authors call the approach feasible and acceptable but note the need for controlled efficacy trials.
The limits
What it doesn't show
Without a control group, pandemic-era substance-use shifts and regression to the mean can explain change. Few participants had diagnosed SUD, and posttreatment completers were a subset of enrollees.
Key terms
- Woebot / W-SUDs
- Text conversational agent adapted for substance-use treatment.
- Conversational agent
- Automated chatbot delivering therapeutic check-ins and skills.
- AUDIT-C
- Brief alcohol screening/severity measure.
- DAST-10
- Drug Abuse Screening Test score for drug-use problems.
- PHQ-8
- Eight-item depression symptom scale used here.
- Single-group pre–post design
- Everyone receives the intervention; change is within-person over time.
Flashcards
Want these cards to stick?
Save the deck to NoteFren and study it with spaced repetition.
Quiz yourself
What delivery modality was tested?
Common questions
How many started W-SUDs?
Analytic sample of 101 participants.
What mood scales were used?
PHQ-8 for depression and GAD-7 for anxiety.
Did cravings change?
Yes—ratings were about half of week-1 levels by weeks 8–9.
Was there a control arm?
No; it was a single-group pre–post study.
More on mHealth